Reuters logo
BRIEF-Ipsen says MHRA has approved a new indication for Decapeptyl
March 13, 2017 / 6:02 AM / 7 months ago

BRIEF-Ipsen says MHRA has approved a new indication for Decapeptyl

March 13 (Reuters) - Ipsen Sa

* Ipsen announces mhra1 approval of new indication for Decapeptyl® for the treatment of pre-menopausal women with early stage breast cancer

* MHRA in UK, in coordination with fourteen other european regulatory agencies, has approved a new indication for Decapeptyl Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below